Wave of Cancer Cell Researches across Globe

.

Wave of Cancer Cell Researches across Globe

As per a data being published in the Nature, it has been revealed that the first volume of a "book of cancer knowledge" has been published. The data explains about some of the details being given the book.

Experts across the globe are of the view that the book will trigger the search for new cancer drugs. In addition, a cancer charity has also said that the book will help researchers to find cancer drugs as per a patient's genetic profile.

The book has revealed that there are millions of cells exist and how it reacts to anti-cancer agents. A lot many papers are being published in regard to cancer cells. Recently, it was found that a team of researchers at the Wellcome Trust Sanger Institute near Cambridge have released two papers, which has discussed about hundreds of cancer cell lines.

In addition, it has also been unveiled that researches have been taking place in different parts of the world, like a team of researchers from the UK have been working with the researchers of US, Paris and Switzerland, to test 130 drugs.

They have claimed to find out clues, which can benefit to patients, like discovery of a rare bone cancer in children. Dr. Mathew Garnett of the Sanger Institute said that they have been trying to find the right drug for each tumor.

He further affirmed, "It's bringing together two very large and very powerful data sets and asking which cell line is the most sensitive and what is behind that sensitivity".

Professor Charles Swanton of the Cancer Research UK's London Research Institute has affirmed that new researches being done on cancer cells will help them to gather valuable information for cancer treatment.


Latest News

Rise in Russian Arms Sales In spite of a Drop Globally
PetSmart Sells itself with an $8.3Billion Deal
Falling Oil Prices Result in a Drop in Stocks
Shares of Amaya Fall Due to Probe Conducted by Securities Regulators
Americans Consumers Display Confidence In the Market with Gain in Sales
It’s Time to Hurry Up to Enrol in the First Phase of Affordable Care Act Health
After Merger with Alliance Boots,	Walgreen CEO will Retire
Falling Fuel Prices Lift Airline Profits But No Respite in Fares Expected
Citigroup to Pay Likely $2.7B as Legal Charge
Michael Jeffries Retires as the CEO of Abercrombie & Fitch
Deutsche Bank in Trouble Again in the U.S. for Alleged Tax Scheme
Popular Demand Brings French Toast Crunch Back on the Shelves